Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

CRVS

Corvus Pharmaceuticals Inc

May 07 • 04:00PM ET

14.59

-0.86 -5.57 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: RCUS NRIX SNDX IOVA RLAY

| Held by: XBI VTI IWM VXF IWO IBB VTWO LFSC IWC VHT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.51	Insider Own	23.76%	Shs Outstand	74.70M	Perf Week	-3.95%
Market Cap	1.23B	Forward P/E	-	EPS next Y	-0.72	Insider Trans	0.00%	Shs Float	64.11M	Perf Month	-1.95%
Enterprise Value	1.17B	PEG	-	EPS next Q	-0.14	Inst Own	38.05%	Short Float	26.40%	Perf Quarter	-23.45%
Income	-15.28M	P/S	-	EPS this Y	-233.16%	Inst Trans	6.11%	Short Ratio	13.24	Perf Half Y	90.97%
Sales	0.00M	P/B	17.81	EPS next Y	-13.22%	ROA	-21.83%	Short Interest	16.93M	Perf YTD	89.48%
Book/sh	0.82	P/C	21.62	EPS next 5Y	-	ROE	-32.60%	52W High	26.95 -45.86%	Perf Year	355.94%
Cash/sh	0.67	P/FCF	-	EPS past 3/5Y	15.40% -21.44%	ROIC	-	52W Low	3.16 360.98%	Perf 3Y	1115.83%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	6.07% 7.29%	Perf 5Y	401.37%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	83.13%	Oper. Margin	-	ATR (14)	1.14	Perf 10Y	20.68%
Dividend Ex-Date	-	Quick Ratio	6.21	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	44.22	Recom	1.14
Dividend Gr. 3/5Y	- -	Current Ratio	6.21	EPS Q/Q	16.20%	SMA20	-6.90%	Beta	0.92	Target Price	33.33
Payout	-	Debt/Eq	0.02	Sales Q/Q	-	SMA50	-5.82%	Rel Volume	1.06	Prev Close	15.45
Employees	37	LT Debt/Eq	0.01	Earnings	May 07 AMC	SMA200	36.00%	Avg Volume	1.28M	Price	14.59
IPO	Mar 23, 2016	Option/Short	Yes / Yes	EPS/Sales Surpr.	-15.92% -	Trades		Volume	1,349,225	Change	-5.57%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)